Skip to main content
Quest Diagnostics Home

Cancer

Quest Advanced™ Oncology is committed to delivering insights into your patients’ health throughout every step of their cancer journey—screening, diagnosis, treatment, prognosis, and monitoring.

Quest is your single-source solution with a comprehensive test menu; over 600 board-certified pathologists, dermatopathologists, and medical experts; leading technology; and committed customer service—delivering the experience of a boutique lab backed by the power of one of the largest labs in the world.

Quest offers its clients a dedicated oncology customer support line to assist with any test-related questions: 1.833.773.1441

Quest Advanced Oncology offers a powerful and comprehensive portfolio of testing that spans the full continuum of cancer care. Quest delivers the resources you need to help make advanced cancer diagnostics more accessible, actionable, and affordable.

About 1 in 3 people in the United States will develop cancer during their lifetime,1 so it’s not uncommon to have many cancers in the same family. Less often, cancers in a family are strongly linked to an inherited gene mutation that is part of a hereditary cancer syndrome.  

Our hereditary cancer solutions help close the gap between the unknown and the path forward. A complete portfolio of hereditary cancer tests, services, and expert analysis from our on-staff genetic counselors help you understand your patients’ risk and are the first step in our approach to supporting a patient’s cancer journey.

Tests include:

  • Comprehensive and guideline-based hereditary cancer panels
  • Cancer-specific panels
  • Hereditary cancer syndrome panels
  • Single-gene and single-site tests

Our genetic counselors are available to consult about test selection and results interpretation. To speak with a genetic counselor, call 1.866.GENE.INFO (1.866.436.3463).

Learn more about our hereditary cancer screening solutions.

 

Supporting excellence in cancer care through precision medicine solutions

Quest Diagnostics offers decision-support tools to help physicians develop a treatment plan for navigating the standard of care and clinical trial options, and beyond. We offer a holistic view of the patient tumor with our Solid Tumor Expanded Panel, a guideline-driven solution for actionable and emerging biomarkers with our Solid Tumor Core Panel, and disease-specific panels for prognosis and treatment decisions.

Our solid tumor solutions include such cancer types as:

⦁    Breast
⦁    Cervical
⦁    GI, Colorectal
⦁    Lung
⦁    Melanoma
⦁    Prostate
⦁    Thyroid

Learn more about our pan-cancer solid tumor solutions

The diagnosis and treatment of cancer is advancing rapidly. Yet for healthcare, cancer remains one of the costliest challenges. To help health systems, community cancer centers, oncologists, and other providers stay ahead, Quest offers a range of oncology solutions from hereditary cancer risk panels to extensive molecular testing.

With a growing list of nearly 50 companion diagnostic tests, Quest’s oncology testing, medical expertise, and technical solutions can help providers, oncologists, and health systems keep pace with the latest diagnostic tools and treatments.

Comprehensive cancer testing portfolio

Breast
Melanoma
Leukemia
Cervical
Myeloma
GI, Colorectal
Myeloproliferative neoplasms
and myelodysplastic syndrome
Leukemia
Ovarian
Lung
Prostate
Lymphoma
Thyroid

Why Quest Advanced™ Oncology

Innovative solutions 

Our highly specialized competencies in hematopathology, solid tumor pathology, dermatopathology, and hereditary cancer screening are empowered by our extensive network of subspecialized pathologists and advanced diagnostic capabilities.

Better outcomes

Advanced testing. Accessible expertise. Industry-leading pathologists. We have one of the broadest specialty menus in the industry, along with medical experts available to consult on test results so you get answers you can trust to provide the superior care your patients deserve.  

Improved experiences

With our robust comprehensive test menu of more than 3,500 oncology tests, you can spend your time caring for patients instead of searching for additional vendors to provide your testing solutions.

The right price

We remove barriers to comprehensive care by improving patient access with comprehensive financial assistance programs and uninsured patient pricing.

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

References

 

  1. American Cancer Society. Family cancer syndromes. Updated August 5, 2020. Accessed August 10, 2020. https://www.cancer.org/cancer/cancer-causes/genetics/family-cancer-syndromes.html


 

Quest's vision for

genomics at scale

Mark Gardner, SVP of Genomic Medicine & Oncology, and Dan Edelstein, President and CEO of Haystack Oncology, sat down with Advisory Board to share their vision for genomics at scale.

Listen now

Cancer

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.